DB
AUGX

Dmitry Balyasny’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Dmitry Balyasny’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,249,723
Closed -$1.1M – 3264
2024
Q2 		$1.1M Buy
1,249,723
+68,795
+6% +$142K ﹤0.01% 1752
2024
Q1 		$4.83M Buy
1,180,928
+682,924
+137% +$3.06M 0.01% 1238
2023
Q4 		$2.91M Sell
498,004
-93,265
-16% -$491K 0.01% 1326
2023
Q3 		$3.05M Buy
591,269
+185,589
+46% +$871K 0.01% 1261
2023
Q2 		$1.95M Buy
+405,680
New +$1.4M ﹤0.01% 1383

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
SM
Samjo Management New York $293M AUM 57.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Dmitry Balyasny's AUGX Position: Q3 2024 in Review

Dmitry Balyasny sold out of Augmedix, Inc. Common Stock (AUGX) in Q3 2024, closing a stake of 1,249,723 shares — an estimated $1.1M sold.

Dmitry Balyasny first reported a position in AUGX in Q2 2023 and held it in 5 quarters. The position peaked at $4.83M in Q1 2024. 45 funds tracked by Wall St. Rank hold AUGX as of Q3 2024.

  • Dmitry Balyasny reported no remaining Augmedix, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Dmitry Balyasny sold 1,249,723 Augmedix, Inc. Common Stock shares in Q3 2024, an estimated $1.1M.
  • Dmitry Balyasny first reported a position in Augmedix, Inc. Common Stock in Q2 2023 and held it in 5 quarters.
  • Dmitry Balyasny's Augmedix, Inc. Common Stock position peaked at $4.83M in Q1 2024.
  • 45 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q3 2024.

Based on Balyasny Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.